Effect of some phosphodiesterase inhibitors on central dopamine mechanisms.

No abstract is available for this paper.

• Publication year

  1976

• Venue

  European Journal of Pharmacology

• Publication date

  1976-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(76)90198-9PMID 182507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of caffeine on locomotor activity and central catecholamine mechanisms: a study with special reference to drug interaction.

  2009cited by this paper
• Antagonism of levodopa by papaverine.

  1975cited by this paper
• Quantitative microfluorimetry of formaldehyde induced fluorescence of dopamine in the caudate nucleus.

  1975cited by this paper
• Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.

  1975cited by this paper
• Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. II. Effects of papaverine.

  1974cited by this paper
• Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists.

  1974cited by this paper
• New inhibitor of reagin-mediated anaphylaxis

  1974cited by this paper
• Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.

  1974cited by this paper
• Antagonism of dopamine-mediated inhibition in the nigro-striatal pathway: a mode of action of some catatonia-inducing drugs.

  1974cited by this paper
• Effects of papaverine on smooth muscle and their mechanisms.

  1974cited by this paper
• Assay of cyclic nucleotide phosphodiesterases with radioactive substrates.

  1974cited by this paper
• Is adenylate cyclase the dopamine receptor?

  1974cited by this paper
• Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

  1972cited by this paper
• Effects of caffeine on central monoamine neurons

  1972cited by this paper
• Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation.

  1972cited by this paper
• A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate.

  1971cited by this paper
• Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

  1971cited by this paper
• 6-Hydroxy-dopamine induced degeneration of central monoamine neurons.

  1968cited by this paper
• Methods of Enzymology.

  1956cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Phosphodiesterase inhibition and Gucy2C activation enhance tyrosine hydroxylase Ser40 phosphorylation and improve 6-hydroxydopamine-induced motor deficits

  2024cites this paper
• Why target brain adenosine receptors? A historical perspective.

  2020cites this paper
• Adenosine A2A-dopamine D2 receptor-receptor interaction in neurons and astrocytes: Evidence and perspectives.

  2020cites this paper
• Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration

  2019cites this paper
• Neurotransmission systems in Parkinson’s disease

  2017cites this paper
• Adenosine Receptor Biology in the Central Nervous System

  2017cites this paper
• Purinergic signaling in Parkinson's disease. Relevance for treatment.

  2016cites this paper
• Caffeine and Neuroprotection in Parkinson’s Disease

  2015cites this paper
• Dopamine heteroreceptor complexes as therapeutic targets in Parkinson’s disease

  2015cites this paper
• Phosphodiesterase 10 inhibitors: new disease modifying drugs for Parkinson's disease?

  2014cites this paper
• Factors influencing serum caffeine concentrations following caffeine ingestion.

  2014cites this paper
• Purinergic Signalling in the Central Nervous System

  2012cites this paper
• Adenosine and ATP receptors in the brain.

  2011cites this paper
• Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice.

  2010cites this paper
• Phosphodiesterases in the central nervous system.

  2009cites this paper
• Addiction and Dose Response: The Psychomotor Stimulant Theory of Addiction Reveals That Hormetic Dose Responses Are Dominant

  2008cites this paper
• Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?

  2008cites this paper
• Role of phosphodiesterases in neurological and psychiatric disease.

  2007cites this paper
• Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease

  2007cites this paper
• Receptor-receptor interactions as an integrative mechanism in nerve cells

  2007cites this paper
• Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease.

  2007cites this paper
• Pharmacological Properties and Neurophsysiological Effects of Caffeine

  2006cites this paper
• Caffeine and activation theory : effects on health and behavior

  2006cites this paper
• Intramembrane receptor–receptor interactions: a novel principle in molecular medicine

  2006cites this paper
• Regulation of multiple forms of cyclic nucleotide phosphodiesterase from bovine hypothalamus: New factors modulating enzyme activity

  2005cites this paper
• Differential display of proteins involved in the neural differentiation of mouse embryonic carcinoma P19 cells by comparative proteomic analysis

  2005cites this paper
• Adenosine and brain function.

  2005cites this paper
• Effects of carbamazepine on morphine-induced behavioral sensitization in mice.

  2004cites this paper
• Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses

  2004cites this paper
• Caffeine and the biological r ole of adenosine r eceptor s

  2003cites this paper
• Pharmacology of adenosine A2A receptors and therapeutic applications.

  2003cites this paper
• The Role of the Hyperpolarization-Activated Cationic CurrentIh in the Timing of Interictal Bursts in the Neonatal Hippocampus

  2003cites this paper
• Adenosine receptors as targets for drug development.

  2003cites this paper
• Adenosine–dopamine interactions

  2003cites this paper
• Caffeine and Central Noradrenaline: Effects on Mood, Cognitive Performance, Eye Movements and Cardiovascular Function

  2003cites this paper
• SCH 58261, an A2A adenosine receptor antagonist, counteracts parkinsonian‐like muscle rigidity in rats

  2001cites this paper
• Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats.

  2001cites this paper
• International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

  2001cites this paper
• Adenosine receptor signaling in vitro and in vivo

  2001cites this paper
• Lack of tolerance to motor stimulant effects of a selective adenosine A(2A) receptor antagonist.

  2000cites this paper
• Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model.

  1999cites this paper
• Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons.

  1999cites this paper
• Distribution, biochemistry and function of striatal adenosine A2A receptors.

  1999cites this paper
• Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

  1999influential citation
• Cellular distribution of adenosine A2A receptor mrna in the primate striatum

  1998cites this paper
• Distribution of adenosine receptors in the postmortem human brain: An extended autoradiographic study

  1997cites this paper
• Adenosine-dopamine interactions in the ventral striatum Implications for the treatment of schizophrenia

  1997cites this paper
• Adenosine and the nervous system: clinical implications.

  1996cites this paper
• Pharmacology of adenosine A2A receptors.

  1996cites this paper
• Neuropharmacology of the adenosine A2A receptors

  1996cites this paper
• Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine.

  1995cites this paper
• Purinoceptors in the nervous system.

  1995cites this paper
• Neuroleptics Up‐Regulate Adenosine A2a Receptors in Rat Striatum: Implications for the Mechanism and the Treatment of Tardive Dyskinesia

  1995cites this paper
• Evidence for the Existence of Antagonistic Intramembrane Adenosine A2a/dopamine D2 Receptor Interactions in the Basal Ganglia: Analysis from the Network to the Molecular Level

  1995cites this paper
• Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration

  1995cites this paper
• On the mechanisms by which theophylline changes core body temperature in mice.

  1994cites this paper
• Interaction between caffeine and clozapine.

  1994cites this paper
• Different influences of adenosine receptor agonists and antagonists on morphine antinociception in mice.

  1994cites this paper
• Caffeine-induced expression of the proto-oncogene c-fos in rat striatum is increased after dopamine denervation.

  1993cites this paper
• Antagonistic A2a/D2 receptor interactions in the striatum as a basis for adenosine/dopamine interactions in the central nervous system

  1993cites this paper
• Neuromodulatory roles of purines

  1993cites this paper
• Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats.

  1993cites this paper
• Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophrenia.

  1992cites this paper
• Adenosine-dopamine interactions in the brain.

  1992cites this paper
• Dopamine denervation leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.

  1992cites this paper
• Methylxanthine‐induced attenuation of pecking in chickens

  1991cites this paper
• Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.

  1991cites this paper
• Reinstatement by caffeine of an extinguished conditioned dopaminergic drug response.

  1990cites this paper
• Adenosine in Central Nervous System Function

  1990cites this paper
• Rotational behaviour induced by theophylline in 6-OHDA nigrostriatal denervated rats is dependent on the supersensitivity of striatal dopaminergic receptors.

  1989cites this paper
• Relationship between rotational behaviour induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway.

  1989cites this paper
• Doxofylline and theophylline are xanthines with partly different mechanisms of action in animals.

  1988cites this paper
• Chronic caffeine or theophylline exposure reduces gamma-aminobutyric acid/benzodiazepine receptor site interactions.

  1988cites this paper
• Adenosine and dopamine function in the CNS

  1987cites this paper
• Interactions between caffeine and adenosine agonists in producing embryo resorptions and malformations in mice.

  1987cites this paper
• Differential down-regulation of D1-stimulated adenylate cyclase activity in rat forebrain after in vivo amphetamine treatments

  1986cites this paper
• Lack of a sustained effect on catecholamines or indoles in mouse brain after long term subcutaneous administration of caffeine and theophylline.

  1986cites this paper
• Methylxanthine discrimination in the rat: possible benzodiazepine and adenosine mechanisms.

  1985cites this paper
• Regulation of multiple forms of cyclic nucleotide phosphodiesterase from bovine hypothalamus: New factors modulating enzyme activity

  1985cites this paper
• Adenosine: an endogenous modulator of hippocampal noradrenaline release.

  1985cites this paper
• Increased anxiogenic effects of caffeine in panic disorders.

  1985cites this paper
• Mammalian Central Adenosine Receptors

  1984cites this paper
• Effects of forskolin analogs, phosphodiesterase inhibitors and 8-bromo cyclic AMP on plasma exudations induced with bradykinin and prostaglandin E1 in rat skin.

  1984cites this paper
• 1-(4-Aminophenyl)isoquinoline derivatives. Potent inhibitors of calcium-independent and calcium-dependent phosphodiesterases from rat cerebral cortex.

  1984cites this paper
• The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans.

  1984cites this paper
• Endogenous adenosine as a modulator of hippocampal acetylcholine release

  1984cites this paper
• On the mechanism by which methylxanthines enhance apomorphine-induced rotation behaviour in the rat.

  1983cites this paper
• Effect of guanine derivatives on lordosis behavior in estrogen primed rats.

  1983cites this paper
• Pharmacological evidence that LH-RH action on lordosis behavior is mediated through a rise in cAMP.

  1982cites this paper
• Adenosine Receptors Mediating Cyclic AMP Productioin the Rat Hippocampus

  1982cites this paper
• Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: evaluation of structure-activity relationships.

  1982cites this paper
• Adenosine receptors and behavioral actions of methylxanthines.

  1981cites this paper
• Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines.

  1981cites this paper
• Facilitation of progesterone induced lordosis behavior by phosphodiesterase inhibitors in estrogen primed rats.

  1981cites this paper
• Role of adenosine in adipose tissue circulation.

  1981cites this paper
• Oxpentifylline in Parkinson's disease.

  1980cites this paper
• Opiate dependence and tolerance: a pharmacological analysis

  1980cites this paper
• Biochemistry of Schizophrenia and Addiction

  1980cites this paper
• DOPAMINE RECEPTORS AND PHOSPHODIESTERASES

  1979cites this paper
• ACTIONS OF ERGOT DERIVATIVES AT DOPAMINE SYNAPSES

  1979cites this paper